Breaking News, Promotions & Moves

ProBioGen Appoints Alfred Merz as CEO

He previously served as company COO and interim CEO, Dr. Merz now leads the company's next phase of growth.

By: Rachel Klemovitch

Assistant Editor

ProBioGen has appointed Dr. Alfred Merz, PhD, as Chief Executive Officer (CEO), effective April 1, 2025. Dr. Merz previously served as Chief Operating Officer (COO) and interim CEO. His expertise will be instrumental in driving the company’s next growth phase while solidifying ProBioGen’s position as a trusted partner in biopharmaceutical development and manufacturing for clinical and commercial supply, recognized for its scientific acumen, client-oriented flexibility, and reliabi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters